Skip to content

Lisata Therapeutics, Inc.

LSTA· NasdaqCore metricsCIK 320017

Pharmaceutical preparations553 peers

Last sale
Oct 8, 2026 · +1.69%
Market cap
$12.96M
10.8M shares
Filings
1,028
$0.00
Q3 2026−83.0% FY24 yoy
-$6.79M
Q3 2026N/M FY24 yoy
-$10.03M
Q3 2026N/M FY24 yoy
-$18.41M
Q3 2026derivedN/M FY24 yoy
-$0.73
Q3 2026N/M FY24 yoy
$282.72M
Q3 2026−1.6% FY24 yoy
$12.96M
—
129.6×
1.7×
-167.08%
—

Twelve months to Sep 30, 2026 · derived

Price

$1.2052.57%$1.33past year
Oct 8, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$170.00KFY 2024
$69.82M0FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2022FY 2023FY 2024
PeriodEndedValueKindSource trail
FY 20242025-12-31$170,000reported
FY 20232024-12-31$1,000,000reported
FY 20222022-12-31$0reported
FY 20162016-12-31$35,283,868reported
FY 20152015-12-31$22,487,566reported
FY 20142014-12-31$17,938,790reported
FY 20132013-12-31$14,668,455reported
FY 20122012-12-31$14,329,889reported
FY 20112011-12-31$10,050,086 revisedreported
FY 20102010-12-31$69,821,294reported

Capital returns

Dividends and buybacks · FY2010 to FY2014
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2014$0.00—$0.00—38.46M sh+34.6%—
FY2013$0.00—$0.00—28.58M sh−83.0%—
FY2012$327.75K—$327.75K—168.41M sh+47.3%—
FY2011$0.00—$0.00—114.35M sh+78.1%—
FY2010$222.92K—$222.92K—64.22M sh——

Pharmaceutical preparations

Lisata Therapeutics, Inc. is the 239th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR